MYK-224

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MYK-224, covering 2025-08-12 to 2026-06-02. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy [Phase 2]

See pricing